131 related articles for article (PubMed ID: 8235258)
21. [Indications and limitations of non-hormonal treatments of osteoporosis].
Avouac B
Rev Fr Gynecol Obstet; 1993; 88(7-9):419-23. PubMed ID: 8235256
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and treatment of postmenopausal osteoporosis].
Mizunuma H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
[No Abstract] [Full Text] [Related]
23. [Estrogen treatment for prevention and therapy of osteoporosis].
von Werder K
Fortschr Med; 1997 Oct; 115(29):44-9. PubMed ID: 9445834
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of osteoporosis using estrogen and gestagens].
Lauritzen C
Gynakologe; 1992 Feb; 25(1):31-5. PubMed ID: 1547979
[No Abstract] [Full Text] [Related]
25. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
Menon KV; Angulo P; Boe GM; Lindor KD
Am J Gastroenterol; 2003 Apr; 98(4):889-92. PubMed ID: 12738473
[TBL] [Abstract][Full Text] [Related]
27. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Neves-E-Castro M
Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
[TBL] [Abstract][Full Text] [Related]
28. The role of menopausal hormone therapy in the management of osteoporosis.
de Villiers TJ
Climacteric; 2015; 18 Suppl 2():19-21. PubMed ID: 26474003
[TBL] [Abstract][Full Text] [Related]
29. [Contemporary views on use of estrogen replacement therapy in postmenopausal women. I. Hormone therapy in women with menopausal osteoporosis].
Krasomski G
Ginekol Pol; 1995 Jan; 66(1):28-31. PubMed ID: 8522210
[TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
31. [Evidence of hormone replacement therapy for osteoporosis].
Tarakida A; Higuchi T; Mizunuma H
Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
33. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
34. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
Pacifici R
J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
[TBL] [Abstract][Full Text] [Related]
35. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
Ste-Marie LG; Schwartz SL; Hossain A; Desaiah D; Gaich GA
J Bone Miner Res; 2006 Feb; 21(2):283-91. PubMed ID: 16418784
[TBL] [Abstract][Full Text] [Related]
36. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
37. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
38. A practical guide to prescribing estrogen replacement therapy.
Corson SL
Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
[TBL] [Abstract][Full Text] [Related]
39. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.
Komm BS; Morgenstern D; A Yamamoto L; Jenkins SN
Expert Rev Clin Pharmacol; 2015; 8(6):769-84. PubMed ID: 26482902
[TBL] [Abstract][Full Text] [Related]
40. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
